Outcomes of Inoperable Symptomatic Aortic Stenosis Patients Not Undergoing Aortic Valve Replacement
Samir Kapadia(Cleveland Clinic), E. Murat Tuzcu(Cleveland Clinic), Vasilis Babaliaros(Valve (United States)), D. Craig Miller(Harvard University), Lars G. Svensson(Cleveland Clinic), John G. Webb(St. Paul's Hospital), Raj Makkar(Cedars-Sinai Medical Center), Pamela S. Douglas(Duke University), Jeffrey W. Moses(Good Samaritan University Hospital), David J. Cohen(Baim Institute for Clinical Research), David L. Brown(Baylor Scott & White Health), William J. Stewart(University of Notre Dame), Martin B. Leon(Columbia University Irving Medical Center), Craig R. Smith(University of Arizona), Ted Feldman(Edwards Lifesciences (United States)), S. Chiu Wong(NewYork–Presbyterian Hospital), William N. Anderson(Edwards Lifesciences (United States))
Cited by 61
Related Papers
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
|Journal of the American Society of Echocardiography|2005|11.3k
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|New England Journal of Medicine|2011|6.4k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k